1
1044 EC Framework Research Programme EC governments are unanimously pushing for more Community funds to go to medi- cal research. They believe money should be diverted from information technology and energy research to finance medical work under the EC’s fourth Framework Research Programme (1994-98). Under the EC Commission’s proposals for Framework Programme budget allo- cations, the life sciences heading-which : covers biotechnology, medical research, and agriculture-food applications of life sciences-would get 10.1 % of the total 13-1 billion ecus. The governments claim that this amount is not enough and life-sciences should get at least 11-1%, many want even more. Member states say that the 30% for telecommunications is far too much. France, Germany, and the UK are also unhappy about the overall cost of the programme, although the Commission claims it would not mean an increase on existing funding in real terms since the fourth programme contains headings that previously came out of other EC budgets. : There is also controversy over the EC’s : nine Joint Research Centres, which the UK, Denmark, and the Netherlands in . particular claim should compete for EC research contracts alongside private insti- tutions and be more market oriented. They claim that the centres should not be funded under the framework programme since that is the equivalent of giving contracts without the centres having to bid. Italy, which houses many of the centres at its Ispra site, : backed by Portugal and the Commission, rejects this view and emphasises that the centres are Community institutions and should be managed as such. : The Commission wants medical research funding priorities to be AIDS, tuberculosis and other infectious diseases, cancer, phar- maceuticals, and neuroscience and brain research. The Commission proposes that the EC help should link researchers in- volved in prevention and treatment of workplace accidents and occupational disease, the epidemiology of illnesses with a major socioeconomic impact, human genome analysis, health services research, biomedical technology, and engineering and biomedical ethics. : EC research ministers will now meet to discuss the proposals in December and the Commission hopes that the programme will be finally approved before the June, 1994, European Parliament elections. However, the deep rift over Joint Research Centre funding looks set to dash this hope. After all, the Commission only released the framework programme proposals in July, and it took 18 months of hard negotiation to approve the third programme. Sara Lewis Not quite a science summit The final ratification of the Maastricht treaty, by Germany, became possible when a qualified endorsement was granted by the German federal constitutional court on Oct v 12, clearing the way for the treaty to come into effect on Nov 1. For the European Parliament, the treaty will introduce new powers of co-decision, which members of the assembly plan to exploit in securing a greater say on research issues and spending. To underline this commitment, the assembly’s Committee on Energy, Re- search, and Technology organised a European science summit in Brussels on Oct 14 and 15. : Scientific it may have been but in no way did this gathering conform to the usual criterion of a summit-that is, a gathering of principals to take important decisions on the basis of consensus hammered out by underlings. Instead, the conference took the form of rambling seminar sessions on subjects such as "science, industry and the quality of life" and "science, culture, ethics and society". Energy committee chairman, Belgian Socialist MEP Prof Claude Desama, commented that it was not too arly to begin looking ahead to the Com- munity’s next five-year research support programme which will begin in 1998. Perhaps unimpressed by the EC commitment to research, given that the Community budget amounts to less than the outlay on sugar subsidies, the scientists spent much of their time discussing un- sympathetic press coverage, the quality of science teaching, the declining interest shown by youngsters in science studies, and the time-honoured ritual pronouncements on the social sciences. Chemistry Nobel laureate Sir John Kendrew commented: "Young people have turned against science. If you ask them why, some say because it is boring but more common is the feeling about the nasty things which science has brought to the world: nuclear weapons, pollution, the ozone hole, and genetic engineering". There were even suggestions that scientists are perhaps the very last people who should be brought together to discuss science, let alone the ethics of science. Arthur Rogers HUGO’s uncertain future? Dr Francis Collins, director of the human genome project (HUGO), claims that lack of funding may prevent sequencing of the human genome by the target date of 2005. He made his comments at last week’s annual meeting of the American Society of Human Genetics in New Orleans after a decision by Congress to allocate US$108 : million to university research (Collins had sought$132 million) and$21 million for a genetics research centre at the National Institutes of Health. However, a spokesperson for the National Centre for Human Genetic Research noted that the 1994 budget for the project had not yet been finalised. : : Collins recently set out a new five-year plan1 for the US human genome project in which he reported that "in some instances, [it was] ahead of schedule". New techno- logies, such as new types of genetic mark- ers, improved systems for cloning, and automated DNA sequencing, have allowed the programme to become even more ambi- tious, he commented. However, Collins warned that these plans depended on annual funding of at least$200 million. For 1994, he estimated that the combined re- sources of NIH and the Department of Energy would need to produce a budget of nearly$250 million. If the latest decision by Congress is confirmed, it will be a bitter blow for Collins, who took up his position as director only in April. Richard Horton 1 Collins F, Galas D. A new five-year plan for the US human genome project. Science 1993; 262: 43-46. Updated goals for HUGO : Ot Genetic map: to complete a 2-5 centimorgan map by 1995. < Physical map: to complete a sequence-tagged site map of the human genome at a : resolution of 100 kilobases. : 8 DNA sequencing: to achieve a sequencing rate of 50 megabases per year. : . Gene identification: to improve methods for locating genes on physical maps or : sequenced DNA. : . Technology development: to take place in all areas, especially sequencing. . Model organisms: expanding sequence data for the genomes of mice, Escherichia : coli, Drosophila, and Caenorhabdities elegans. : < Informatics: to expand, distribute, and improve access to all genome databases. : . Ethical issues: to refine and disseminate policy options on genome research and genetic testing; improve public education ; and foster greater acceptance of human : genetic variation. . Technology transfer: to take place in all areas of genome research. : . Outreach: to encourage the sharing of data within six months of their acquisition.

Not quite a science summit

Embed Size (px)

Citation preview

1044

EC Framework Research

Programme

EC governments are unanimously pushingfor more Community funds to go to medi-cal research. They believe money should bediverted from information technology andenergy research to finance medical workunder the EC’s fourth FrameworkResearch Programme (1994-98). Under theEC Commission’s proposals forFramework Programme budget allo-

cations, the life sciences heading-which :covers biotechnology, medical research,and agriculture-food applications of lifesciences-would get 10.1 % of the total 13-1billion ecus. The governments claim thatthis amount is not enough and life-sciencesshould get at least 11-1%, many want evenmore. Member states say that the 30% fortelecommunications is far too much.

France, Germany, and the UK are alsounhappy about the overall cost of the

programme, although the Commissionclaims it would not mean an increase onexisting funding in real terms since thefourth programme contains headings thatpreviously came out of other EC budgets. :There is also controversy over the EC’s :

nine Joint Research Centres, which theUK, Denmark, and the Netherlands in .particular claim should compete for ECresearch contracts alongside private insti-tutions and be more market oriented. Theyclaim that the centres should not be fundedunder the framework programme since thatis the equivalent of giving contracts withoutthe centres having to bid. Italy, whichhouses many of the centres at its Ispra site, :backed by Portugal and the Commission,rejects this view and emphasises that thecentres are Community institutions andshould be managed as such. :The Commission wants medical research

funding priorities to be AIDS, tuberculosisand other infectious diseases, cancer, phar-maceuticals, and neuroscience and brainresearch. The Commission proposes thatthe EC help should link researchers in-volved in prevention and treatment ofworkplace accidents and occupationaldisease, the epidemiology of illnesses with amajor socioeconomic impact, human

genome analysis, health services research,biomedical technology, and engineeringand biomedical ethics. :EC research ministers will now meet to

discuss the proposals in December and theCommission hopes that the programmewill be finally approved before the June,1994, European Parliament elections.

However, the deep rift over Joint ResearchCentre funding looks set to dash this hope.After all, the Commission only released theframework programme proposals in July,and it took 18 months of hard negotiation toapprove the third programme.

Sara Lewis

Not quite a sciencesummit

The final ratification of the Maastricht

treaty, by Germany, became possible whena qualified endorsement was granted by theGerman federal constitutional court on Oct v12, clearing the way for the treaty to comeinto effect on Nov 1. For the EuropeanParliament, the treaty will introduce newpowers of co-decision, which members ofthe assembly plan to exploit in securing agreater say on research issues and spending.To underline this commitment, theassembly’s Committee on Energy, Re-

search, and Technology organised aEuropean science summit in Brussels onOct 14 and 15. :

Scientific it may have been but in no waydid this gathering conform to the usualcriterion of a summit-that is, a gatheringof principals to take important decisions onthe basis of consensus hammered out byunderlings. Instead, the conference tookthe form of rambling seminar sessions onsubjects such as "science, industry and thequality of life" and "science, culture, ethicsand society". Energy committee chairman,

Belgian Socialist MEP Prof Claude

Desama, commented that it was not too

arly to begin looking ahead to the Com-munity’s next five-year research supportprogramme which will begin in 1998.Perhaps unimpressed by the EC

commitment to research, given that theCommunity budget amounts to less thanthe outlay on sugar subsidies, the scientistsspent much of their time discussing un-sympathetic press coverage, the quality ofscience teaching, the declining interestshown by youngsters in science studies, andthe time-honoured ritual pronouncementson the social sciences. Chemistry Nobellaureate Sir John Kendrew commented:"Young people have turned againstscience. If you ask them why, some saybecause it is boring but more common is thefeeling about the nasty things which sciencehas brought to the world: nuclear weapons,pollution, the ozone hole, and geneticengineering". There were even suggestionsthat scientists are perhaps the very last

people who should be brought together todiscuss science, let alone the ethics ofscience.

Arthur Rogers

HUGO’s uncertain future?

Dr Francis Collins, director of the humangenome project (HUGO), claims that lackof funding may prevent sequencing of thehuman genome by the target date of 2005.He made his comments at last week’sannual meeting of the American Society ofHuman Genetics in New Orleans after adecision by Congress to allocate US$108 :million to university research (Collins hadsought$132 million) and$21 million for agenetics research centre at the NationalInstitutes of Health. However, aspokesperson for the National Centre forHuman Genetic Research noted that the1994 budget for the project had not yet beenfinalised. :

: Collins recently set out a new five-yearplan1 for the US human genome project in

which he reported that "in some instances,[it was] ahead of schedule". New techno-logies, such as new types of genetic mark-ers, improved systems for cloning, andautomated DNA sequencing, have allowedthe programme to become even more ambi-

tious, he commented. However, Collinswarned that these plans depended onannual funding of at least$200 million. For1994, he estimated that the combined re-sources of NIH and the Department ofEnergy would need to produce a budget ofnearly$250 million. If the latest decision byCongress is confirmed, it will be a bitterblow for Collins, who took up his positionas director only in April.

Richard Horton

1 Collins F, Galas D. A new five-year plan forthe US human genome project. Science 1993;262: 43-46.

Updated goals for HUGO: Ot Genetic map: to complete a 2-5 centimorgan map by 1995.

< Physical map: to complete a sequence-tagged site map of the human genome at a: resolution of 100 kilobases.: 8 DNA sequencing: to achieve a sequencing rate of 50 megabases per year.: . Gene identification: to improve methods for locating genes on physical maps or: sequenced DNA.: . Technology development: to take place in all areas, especially sequencing.

. Model organisms: expanding sequence data for the genomes of mice, Escherichia: coli, Drosophila, and Caenorhabdities elegans.: < Informatics: to expand, distribute, and improve access to all genome databases.: . Ethical issues: to refine and disseminate policy options on genome research and

genetic testing; improve public education ; and foster greater acceptance of human: genetic variation.

. Technology transfer: to take place in all areas of genome research.: . Outreach: to encourage the sharing of data within six months of their acquisition.